Brief Report: Clinical Response, Toxicity, and Resistance Mechanisms to Osimertinib Plus MET Inhibitors in Patients with EGFR-Mutant MET-Amplified NSCLC
JTO CLINICAL AND RESEARCH REPORTS(2023)
Key words
Resistance mechanisms,MET,EGFR,NSCLC
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined